Lin PT - Search Results

1

Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor.

Lin PT, Hsu YC, Kao YT, Teng W, Hsieh YC, Chen WT, Su CW, Wang CT, Chai PM, Lin CC, Lin CY, Lin SM. Lin PT, et al. Am J Cancer Res. 2024 Mar 15;14(3):1306-1315. doi: 10.62347/GFVP1262. eCollection 2024. Am J Cancer Res. 2024. PMID: 38590407 Free PMC article.

2

Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.

Su CW, Teng W, Shen EY, Huang BS, Lin PT, Hou MM, Wu TH, Tsan DL, Hsieh CH, Wang CT, Chai PM, Lin CY, Lin SM, Lin CC. Su CW, et al. Among authors: lin pt. Oncologist. 2024 Mar 26:oyae048. doi: 10.1093/oncolo/oyae048. Online ahead of print. Oncologist. 2024. PMID: 38530254 Free article.

3

The Mini Nutritional Assessment combined with body fat for detecting the risk of sarcopenia and sarcopenic obesity in metabolic syndrome.

Yen CH, Lee YW, Chang WJ, Lin PT. Yen CH, et al. Among authors: lin pt. Br J Nutr. 2024 May 28;131(10):1659-1667. doi: 10.1017/S0007114524000369. Epub 2024 Feb 5. Br J Nutr. 2024. PMID: 38312003

4

Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment.

Lin PT, Teng W, Jeng WJ, Lin CC, Lin CY, Lin SM, Sheen IS. Lin PT, et al. J Formos Med Assoc. 2024 Feb 2:S0929-6646(24)00084-6. doi: 10.1016/j.jfma.2024.01.031. Online ahead of print. J Formos Med Assoc. 2024. PMID: 38310071 Free article.

5

Does a collecting system injury with grade iv renal blunt trauma always need urinary intervention?

Lin PT, Lin YH, Tee YS, Cheng CT, Liao CH, Hsieh CH, Fu CY. Lin PT, et al. World J Urol. 2024 Jan 8;42(1):15. doi: 10.1007/s00345-023-04710-7. World J Urol. 2024. PMID: 38189994

6

Protein and lipid expansion microscopy with trypsin and tyramide signal amplification for 3D imaging.

Wang UT, Tian X, Liou YH, Lee SP, Hu HT, Lu CH, Lin PT, Cheng YJ, Chen P, Chen BC. Wang UT, et al. Among authors: lin pt. Sci Rep. 2023 Dec 8;13(1):21922. doi: 10.1038/s41598-023-48959-9. Sci Rep. 2023. PMID: 38081848 Free PMC article.

7

A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefit.

Su CW, Teng W, Lin PT, Wu TH, Hsu YC, Hsieh YC, Huang CH, Chen WT, Lin CC, Lin CY, Lin SM. Su CW, et al. Among authors: lin pt. Am J Cancer Res. 2023 Nov 15;13(11):5482-5492. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058809 Free PMC article.

8

Advancing Our Knowledge of Cognition in Disorders of Consciousness: A Critical Revisit.

Lin PT, Yu HY. Lin PT, et al. Acta Neurol Taiwan. 2024 Mar 30;33(1):43-47. Acta Neurol Taiwan. 2024. PMID: 37994104 Review.

9

Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.

Hsieh RC, Lee CH, Huang HC, Wu SW, Chou CY, Hung SP, Lee CW, Krishnan S, Venkatesulu BP, Lee JC, Chou YC, Chan KM, Lin PT, Lee WC, Lin CC, Lin SY, Hong JH. Hsieh RC, et al. Among authors: lin pt. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):712-724. doi: 10.1016/j.ijrobp.2023.09.049. Epub 2023 Sep 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 37778426

10

Yeast cell detection using fuzzy automatic contrast enhancement (FACE) and you only look once (YOLO).

Huang ZJ, Patel B, Lu WH, Yang TY, Tung WC, Bučinskas V, Greitans M, Wu YW, Lin PT. Huang ZJ, et al. Among authors: lin pt. Sci Rep. 2023 Sep 27;13(1):16222. doi: 10.1038/s41598-023-43452-9. Sci Rep. 2023. PMID: 37758830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page